The Difference in the Effectiveness of Anti-IL-5 Antibodies and Anti-IL-5rα Antibodies in Severe Bronchial Asthma

被引：0
|
作者：
Nishimura, N. [1 ]
Imai, R. [1 ]
Nakamura, T. [1 ]
So, C. [1 ]
Okafuji, K. [1 ]
Kitamura, A. [1 ]
Tomishima, Y. [1 ]
Jinta, T. [1 ]
机构：
[1] St Lukes Int Hosp, Thorac Ctr, Dept Pulm Med, Chuo City, Tokyo, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5390
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-world effectiveness of anti-IL-5/5R therapy in severe eosinophilic asthma with comorbid bronchiectasis
    van Nederveen-Bendien, S. A.
    Kroes, H.
    Maitland-Van Der Zee, A.
    Ten Brinke, A.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [22] Anti-IL-5 for Severe Asthma Aiming High to Achieve Success
    Russell, Richard
    Brightling, Christopher E.
    CHEST, 2016, 150 (04) : 766 - 768
  • [23] Effectiveness of anti-IgE and anti-IL-5 treatment in step 5 asthma patients.
    Saji, Junko
    Muraoka, Hiromi
    Nishimoto, Eriko
    Matsuzawa, Shin
    Okamoto, Mariko
    Inoue, Teppei
    Handa, Hiroshi
    Nishine, Hiroki
    Inoue, Takeo
    Miyazawa, Teruomi
    Mineshita, Masamichi
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [24] Real World Effectiveness And Safety Of Anti-Il-5/mepolizumab In An Academic Severe Asthma Clinic
    Zhang, P.
    Vitari, C. A.
    Wenzel, S. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [25] Cost-effectiveness analysis of anti-IL-5 therapies of severe eosinophilic asthma in Spain
    Gonzalez-Barcala, Francisco Javier
    Munoz-Gall, Xavier
    Mariscal, Esther
    Garcia, Andrea
    Yang, Shibing
    van de Wetering, Gijs
    Izquierdo-Alonso, Jose Luis
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 874 - 882
  • [26] Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics
    Principe, Stefania
    Benfante, Alida
    Calzetta, Luigino
    Rogliani, Paola
    Scichilone, Nicola
    WORLD ALLERGY ORGANIZATION JOURNAL, 2019, 12 (11):
  • [27] Anti-IL-5 therapy and the airway microbiome in asthma
    Sullivan, Ashley
    Ward, Chris
    Casey, Deborah
    Flynn, Deirdre
    Hunt, Eoin B.
    Eustace, Joseph A.
    O'Byrne, Paul M.
    Plant, Barry J.
    Macsharry, John A.
    Murphy, Desmond M.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [28] Mechanism of extended duration of anti-IL-5 antibodies against pulmonary eosinophilia
    Egan, RW
    Wang, P
    Garlisi, C
    Mauser, P
    Chapman, RW
    Kreutner, W
    Umland, SP
    Kung, TT
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 496 - 496
  • [29] Anti-IL-5 treatments in severe eosinophilic asthma: real life datas
    Ozdel Ozturk, Betul
    Bavbek, Sevim
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2020, 68 (02): : 148 - 159
  • [30] Anti-IL-5 biologics carve out severe-asthma niche
    Elie Dolgin
    Nature Biotechnology, 2014, 32 : 1075 - 1076
12345